Stockreport

Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026 [CNBC]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF While Novo is bracing for a sales decline, Lilly sees revenue charging ahead thanks to its blockbuster medicines. The split in guidance underscores Lilly's stronger p [Read more]